Asia-Pacific: The Fastest-Growing Region for Bioprocess Technology Adoption The Asia-Pacific (APAC) region is rapidly transforming into a major global biopharma hub and is projected to be the fastest-growing market for Bioprocess Technology. Valued at $5.5 Billion in 2023, the APAC market is expected to surge to $9.5 Billion by 2032. This impressive growth rate is driven by a confluence of factors, including increasing government investment in local biomanufacturing...